These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18363451)

  • 1. High-dose olanzapine for treatment-resistant schizophrenia.
    Roth BL
    J Clin Psychiatry; 2008 Feb; 69(2):176-7. PubMed ID: 18363451
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of serotonin receptor 2A gene haplotypes on C-peptide levels in clozapine- and olanzapine-treated patients.
    Melkersson KI; Gunes A; Dahl ML
    Hum Psychopharmacol; 2010; 25(4):347-52. PubMed ID: 20521326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose olanzapine versus clozapine.
    Mattes JA
    J Clin Psychiatry; 2008 Oct; 69(10):1660; author reply 1660-1. PubMed ID: 19192450
    [No Abstract]   [Full Text] [Related]  

  • 6. Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine.
    Bobb VT; Jarskog LF; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):539-43. PubMed ID: 21186975
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic.
    Thinn SS; Liew E; May AL; Chua HC; Sim K
    J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of antipsychotic drugs.
    Messori A
    Am J Psychiatry; 2003 Mar; 160(3):591-2; author reply 592-3. PubMed ID: 12611854
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.
    Conley RR; Kelly DL; Beason-Held LL; Holcomb HH; Richardson CM
    J Psychopharmacol; 2004 Sep; 18(3):429-31. PubMed ID: 15358989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.
    Naber D; Riedel M; Klimke A; Vorbach EU; Lambert M; Kühn KU; Bender S; Bandelow B; Lemmer W; Moritz S; Dittmann RW
    Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
    Szota A; Ogłodek E; Araszkiewicz A
    Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.
    Conley RR; Kelly DL; Richardson CM; Tamminga CA; Carpenter WT
    J Clin Psychopharmacol; 2003 Dec; 23(6):668-71. PubMed ID: 14624201
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.
    Souza JS; Kayo M; Tassell I; Martins CB; Elkis H
    CNS Spectr; 2013 Apr; 18(2):82-9. PubMed ID: 23253621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia past clozapine: what works?
    Mustafa FA
    J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine.
    Tollefson GD; Birkett MA; Kiesler GM; Wood AJ;
    Biol Psychiatry; 2001 Jan; 49(1):52-63. PubMed ID: 11163780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 20. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.